4 "Lucky" Stocks to Watch on Friday 🍀

The Nasdaq rallied 2.4% on Thursday as investors reacted to news that Wall Street was planning to come the regional banking sector's rescue. The Dow added 1.1%, and the S&P 500 jumped 1.7%, while the small-cap Russell 2K added 1.7%.

Futures are looking shaky in early morning trading. S&P 500 contracts are currently showing a 0.1% loss.

Five Growth Stocks to Watch Closely...

One of these 5 stocks has produced 18 positive returns for its shareholders over the past two decades alone.

Another is experiencing a current supply-demand imbalance in the market which has contributed to high prices - which is great for investors...

Click Here to See All 5 Stocks.

💰 Wall Street Banks Rescue First Republic

Eleven banks have deposited a combined total of $30 billion with First Republic Bank [FRC] in an effort a shore up the bank's liquidity against a spreading banking in the regional banking sector.

Sources say Treasury Sect. Janet Yellen and other Washington officials worked closely with the banks involved in the rescue.

FedEx is rallying on the heels of a strong earnings report.

The shipping giant released its fiscal Q3 results after Thursday's close, and the market was very impressed with what it saw.

FedEx's fiscal Q3 EPS of $3.41 beat the Street's $2.73 per share estimate, but revenues of $22.2 billion fell short of Wall Street's target.

However, the company said it's making progress in its efforts to shave $3.7 billion in costs from its global delivery business and hiked its full-year guidance.

FDX is this morning's top S&P 500 stock with an 11.6% gain.

My Take: FDX appears to be on the right track, but an economic slowdown can be a major headwind for shipping companies. Sentiment appears to be behind the stock for now, but I would be wary of a long-term investment at this time.

Enzo Biochem just landed a huge deal to sell some key assets.

The life sciences company announced on Thursday that it has agreed to sell its clinical lab assets to Laboratory Corp of America [LH].

Under the terms of the deal, Enzo Biochem will receive about $146 million in cash, according to a company press release.

Completion of the sale is contingent on Enzo Biochem shareholders' approval, which the company plans to obtain at an upcoming special meeting.

ENZ is today's top premarket performer with a 68.0% gain on active premarket trading volume.

My Take: The market likes the deal, but ENZ's chart is ugly. This stock has had a rough 12 months, and I'm not sure if this news will give it the boost it needs to break out of its long-term funk.

Histogen is pushing higher after a Thursday evening announcement.

The clinical-stage therapeutics company was issued a U.S. patent that will cover its portfolio of anti-inflammatory caspase inhibitors, such as CTS-2090.

Histogen was awarded Patent No. 11,579,703 titled, "“Caspase Inhibitors and Methods of Use Thereof,” from the US Patent & Trademark Office.

This patent notes that Histogen's CTS-2090 has demonstrated potent oral activity in a well characterized model of ulcerative colitis.

A Histogen spokesperson said the patent "builds upon Histogen’s growing proprietary caspase inhibitor portfolio," which includes another patent issued in September 2022.

HSTO is one of this morning's top stocks with a 32.2% gain on active trading volume.

My Take: If Histogen continues to acquire intellectual property at this rate, it could become a Big Pharma buyout target. This stock could be worth keeping an eye on in the weeks and months ahead.

Hub Cyber is running hot in the wake of a recent announcement.

Earlier this week, the cybersecurity company announced it had made a $4 million sale of its common stock to PIPE investors at a price of $10 per share.

Shares of HUBC have been rallying since the announcement was made. Since Monday's close, shares are up 58%.

Today, this stock is adding to its gains, despite no additional news to explain the push higher.

HUBC is up 23.4% in today's premarket, and it's one of this morning's most active stocks.

My Take: There has been a lot of activity in HUBC since it made its market debut earlier in the month. This stock could have long-term growth potential, as it seems to have Wall Street behind it.

Xpeng Inc. Dr [XPEV] ... AM
Waterdrop Inc. Dr [WDH] ... AM
Tuniu Corporation Dr [TOUR] ... AM
Gigacloud Technology Inc [GCT] ... AM
Dynagas Lng Partners Lp [DLNG] ... AM
Nortech Systems Incorporated [NSYS] ... AM